Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7389
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,896.62
    +1,992.91 (+2.12%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ futures

    18,465.00
    -38.75 (-0.21%)
     
  • VOLATILITY

    13.01
    +0.23 (+1.80%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6845
    +0.0040 (+0.59%)
     

Research Reports Initiated on Healthcare Stocks Medifocus, Ceapro, and Crescita Therapeutics

LONDON, UK / ACCESSWIRE / April 6, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include Medifocus, Ceapro, and Crescita Therapeutics. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

On Wednesday, April 05, 2017, the TSX Venture Composite Index was down 0.17%, finishing the day at 820.30. The Toronto Exchange Composite Index, on the other hand, closed at 15,642.99, down 0.17%.

Additionally, the Healthcare index was down by 1.83%, ending the session at 64.85.

ADVERTISEMENT

Active Wall St. has initiated research reports on the following equities: Medifocus Inc. (TSX-V: MFS), Ceapro Inc. (TSX-V: CZO), and Crescita Therapeutics Inc. (TSX: CTX). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Medifocus Inc.

On Wednesday, shares in Columbia, Maryland headquartered Medifocus Inc. recorded a trading volume of 35,000 shares. The stock ended the day flat at $0.04. Shares of the Company, which develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the US, has rallied 100.00% both, in the last one month and in the previous three months. The Company's shares are trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $0.03 is above its 200-day moving average of $0.02. See our research report on MFS.V at:

http://www.activewallst.com/register/

Ceapro Inc.

On Wednesday, shares in Edmonton, Canada headquartered Ceapro Inc. ended the session 5.33% higher at $1.58 with a total volume of 422,266 shares traded. Ceapro's shares have surged 1.94% in the last one month and 216.00% in the previous one year. Shares of the Company are trading above its 50-day moving average. Furthermore, the stock's 200-day moving average of $1.63 is greater than its 50-day moving average of $1.48. Shares of Ceapro, which engages in developing and commercializing functionally active ingredients for human and animal health markets through the use of proprietary technology and renewable and sustainable resources, are trading at a PE ratio of 15.34. Register for free and access the latest research report on CZO.V at:

http://www.activewallst.com/register/

Crescita Therapeutics Inc.

Shares of Mississauga, Canada headquartered Crescita Therapeutics Inc., which owns topical products for treating medical conditions in dermatology and pain, closed the day 7.92% higher at $1.09. The stock recorded a trading volume of 6,974 shares during the session. Get free access to your research report on CTX.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com
Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street